BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3799213)

  • 1. Prodrugs of 5-fluorouracil. VII. Hydrolysis kinetics and physicochemical properties of N-ethoxy- and N-phenoxycarbonyloxymethyl derivatives of 5-fluorouracil.
    Buur A; Bundgaard H; Falch E
    Acta Pharm Suec; 1986; 23(4):205-16. PubMed ID: 3799213
    [No Abstract]   [Full Text] [Related]  

  • 2. Prodrugs of 5-fluorouracil. V. 1-Alkoxycarbonyl derivatives as potential prodrug forms for improved rectal or oral delivery of 5-fluorouracil.
    Buur A; Bundgaard H
    J Pharm Sci; 1986 May; 75(5):522-7. PubMed ID: 3735094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biological degradation of 5-fluorouracil prodrugs having high serum albumin binding potencies.
    Suda Y; Shimidzu K; Sumi M; Kusumoto S; Nadai T; Yamashita S
    Biol Pharm Bull; 1993 Mar; 16(3):322-4. PubMed ID: 8364483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Alkylated derivatives of 5-fluorouracil.
    Kundu NG; Schmitz SA
    J Pharm Sci; 1982 Aug; 71(8):935-8. PubMed ID: 7120102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of group substitution on the physicochemical properties of ibuprofen prodrugs.
    Bansal AK; Khar RK; Dubey R; Sharma AK
    Pharmazie; 1994 Jun; 49(6):422-4. PubMed ID: 8047542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and properties of 5-fluorouracil derivatives].
    Semakov AV; Blinkov AA; Gaenko GP; Vostrova AG; Molotkovskiĭ IuG
    Bioorg Khim; 2013; 39(3):338-45. PubMed ID: 24397032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis of 5-fluorouracil derivatives containing alkanoic acid].
    Xu LH; Weng LL; Zheng H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):644-6. PubMed ID: 16909623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A topological study of prodrugs of 5-fluorouracil.
    Quigley JM; Lloyd DG
    Int J Pharm; 2002 Jan; 231(2):241-51. PubMed ID: 11755276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical properties of pyrimidine and purine antimetabolites. II. Permeation of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil through cellophane, collagen, and silicone membranes.
    Nakano M; Arakawa Y; Juni K; Arita T
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2716-22. PubMed ID: 1017106
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice.
    McElhinney RS; McCormick JE; Bibby MC; Double JA; Atassi G; Dumont P; Pratesi G; Radacic M
    Anticancer Drug Des; 1989 Jun; 4(1):1-20. PubMed ID: 2757750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timolol prodrugs: preparation and hydrolysis kinetics of N-benzoyl carbamate esters of timolol and related compounds.
    Bundgaard H; Buur A; Lee VH
    Acta Pharm Suec; 1988; 25(6):293-306. PubMed ID: 3245455
    [No Abstract]   [Full Text] [Related]  

  • 13. 1-Alkylcarbonyloxymethyl prodrugs of 5-fluorouracil (5-FU): synthesis, physicochemical properties, and topical delivery of 5-FU.
    Taylor HE; Sloan KB
    J Pharm Sci; 1998 Jan; 87(1):15-20. PubMed ID: 9452962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of energy characteristics of 5-fluorouracil analogs by photoionization mass-spectrometry].
    Orlov VM; Pustobaev VN; Mikhaĭlov SN; Varshavskiĭ IaM; Ludzina AS
    Bioorg Khim; 1984 Apr; 10(4):528-35. PubMed ID: 6497910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of 1- or 3-(alpha-hetero substituted)alkyl-5-fluorouracil derivatives.
    Ozaki S; Nagase T; Ahmad S; Tamai H; Hoshi A; Iigo M
    Nucleic Acids Symp Ser; 1987; (18):1-4. PubMed ID: 3697106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatographic analysis of pharmaceuticals based on pyrimidine and purine substances.
    Miller V; Pacáková V; Smolková E
    J Chromatogr; 1976 Jul; 123(1):216-9. PubMed ID: 950354
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfenamides as prodrugs of NH-acidic compounds: a new prodrug option for the amide bond.
    Guarino VR; Karunaratne V; Stella VJ
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4910-3. PubMed ID: 17604170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urinary metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftoraful).
    Benvenuto JA; Liehr JG; Winkler T; Farquhar D; Caprioli RM; Loo TL
    Cancer Res; 1979 Aug; 39(8):3199-201. PubMed ID: 378368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of physicochemical properties and degradation kinetics of triamcinolone acetonide palmitate in vitro.
    Peng C; Liu C; Tang X
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1469-76. PubMed ID: 20524902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of N1-(aryl)alkyloxyacyl-5-fluorouracil derivatives].
    Hai L; Wu LY; Huang J; Cheng L; Wu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):552-4. PubMed ID: 15291126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.